➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Merck
Baxter
Colorcon
Dow

Last Updated: May 17, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Teva Pharmaceuticals USA, Inc. (S.D.N.Y. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Purdue Pharma L.P. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Get Started Free and   Get Started Free .

Details for Purdue Pharma L.P. v. Teva Pharmaceuticals USA, Inc. (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2013-05-08 10 Order Page 3 of 4 d) U.S. Patent No. 7,682,072 e) U.S. Patent No. 7,776,314 f) U.S. Patent No. 8,114,383 The…following patents: a) U.S. Patent No. 6,488,963 b) U.S. Patent No. 7,674,799 c) U.S. Patent No. 7,674,800…at issue in the patents listed herein. The Markman hearing will not address U.S. Patent No. 8,309,060, …the only other patent currently at issue in the above-listed actions, nor will that patent be a subject …hearing Will not address U.S. Patent No. 8,309,060, the only other patent currently at issue in the above-listed External link to document
2013-08-23 102 ¢ U.S. Patent No. 6,488,963 (”’963 Patent”) (Rabenstein Decl., Ex. A) 0 U.S. Patent No. 7,763,314 (”…”LoW-ABUK Patents": ~ U.S. Patent No. 7,674,799 (”’799 Patent”) (PTX 2)‘1 ~ U.S. Patent No. 7,674,800…three Low-ABUK Patents: v U.S. Patent No. 7,674,799 0 U.S. Patent No. 7,674,800 v U.S. Patent No. 7,683,072…(”’314 Patent”) (Rabenstein Decl., Ex. B) 0 U.S. Patent No. 8,114,383 (”’383 Patent") (Rabenstein…Abuse-Proof Patents in suit. B. Construction of the Disputed Claims in the ’963 Patent The ’963 Patent is a External link to document
2014-01-13 149 not infringe claims 1, 2, 6, and 9 of U.S. Patent No. 7,776,314. 3. A further declaratory judgment shall…and 19 of U.S. Patent No. 7,674,799 are invalid. b. Claims 30-34 and 76-79 of U.S. Patent No. 7,674,8007,674,800 are invalid. c. Claims 1, 4, and 5 of U.S. Patent No. 7,683,072 are invalid. d. Teva's proposed products…Grunenthal GmbH, that claims 1, 2, 5, 7, and 8 of U.S. Patent No. 8,114,383 are invalid. 4, No attorneys fees…2011 14 January 2014 1:11-cv-02037 830 Patent None District Court, S.D. New York External link to document
2014-01-21 150 not infringe claims 1, 2, 6, and 9 of U.S. Patent No. 7,776,314. 3. A further declaratory judgment is entered…and 19 of U.S. Patent No. 7,674,799 are invalid. b. Claims 30-34 and 76-79 of U.S. Patent No. 7,674,8007,674,800 are invalid. c. Claims 1, 4, and 5 of U.S. Patent No. 7,683,072 are invalid. d. Teva's proposed products…Grunenthal GmbH, that claims 1, 2, 5, 7, and 8 of U.S. Patent No. 8,114,383 are invalid. 4. No attorneys fees…2011 14 January 2014 1:11-cv-02037 830 Patent None District Court, S.D. New York External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Express Scripts
Merck
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.